Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dodion

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Cancer Treatment Reports|May 1, 1986
Effect of hyperthermia on the in vitro metabolism of doxorubicinP Dodion, C E Riggs, S R Akman, et al.
Acta Clinica Belgica|January 1, 1991
[Value of CEA levels and of immunoscintigraphy (using CEA-marked antibodies) for the diagnosis and therapeutic monitoring of breast cancer: apropos of a case]L Doalto, R Paridaens, P Dodion, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Validation of clinical predictive value of in vitro colorimetric chemosensitivity assay in head and neck cancerW Schroyens, E Tueni, P Dodion, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1986
Phase II study of a combination of hydroxyurea, fluorouracil and mitomycin in previously treated squamous cell carcinoma of the head and neckP Dodion, F Cognetti, M van Rymenant, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1988
Comparative effect of cisplatin, spiroplatin, carboplatin, iproplatin and JM40 in a human myeloid clonogenic assayW A Schroyens, J B Meeker, P Dodion, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1984
The murine metabolism and disposition of marcellomycinP Dodion, M J Egorin, J M Tamburini, et al.
Investigational New Drugs|January 1, 1985
Human pharmacokinetics of esorubicin (4'-deoxydoxorubicin)P Dodion, T A Davis, M Rozencweig, et al.
Cancer Research|June 1, 1986
Comparative anthracycline metabolism in rats: loss of marcellomycin fluorescenceP Dodion, J M Tamburini, B M Fox, et al.
Investigational New Drugs|January 1, 1986
Phase I study of oral idarubicin given with a weekly scheduleP Dodion, C Finet, N Crespeigne, et al.
American Journal of Clinical Oncology|December 1, 1987
Validation of the clinical predictive values of the in vitro phase II clonogenic assay in cancer of the breast and ovaryM Staquet, B W Brown, M Rozencweig, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Cancer Treatment Reports|May 1, 1986
Effect of hyperthermia on the in vitro metabolism of doxorubicinP Dodion, C E Riggs, S R Akman, et al.
Acta Clinica Belgica|January 1, 1991
[Value of CEA levels and of immunoscintigraphy (using CEA-marked antibodies) for the diagnosis and therapeutic monitoring of breast cancer: apropos of a case]L Doalto, R Paridaens, P Dodion, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Validation of clinical predictive value of in vitro colorimetric chemosensitivity assay in head and neck cancerW Schroyens, E Tueni, P Dodion, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1986
Phase II study of a combination of hydroxyurea, fluorouracil and mitomycin in previously treated squamous cell carcinoma of the head and neckP Dodion, F Cognetti, M van Rymenant, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1988
Comparative effect of cisplatin, spiroplatin, carboplatin, iproplatin and JM40 in a human myeloid clonogenic assayW A Schroyens, J B Meeker, P Dodion, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1984
The murine metabolism and disposition of marcellomycinP Dodion, M J Egorin, J M Tamburini, et al.
Investigational New Drugs|January 1, 1985
Human pharmacokinetics of esorubicin (4'-deoxydoxorubicin)P Dodion, T A Davis, M Rozencweig, et al.
Cancer Research|June 1, 1986
Comparative anthracycline metabolism in rats: loss of marcellomycin fluorescenceP Dodion, J M Tamburini, B M Fox, et al.
Investigational New Drugs|January 1, 1986
Phase I study of oral idarubicin given with a weekly scheduleP Dodion, C Finet, N Crespeigne, et al.
American Journal of Clinical Oncology|December 1, 1987
Validation of the clinical predictive values of the in vitro phase II clonogenic assay in cancer of the breast and ovaryM Staquet, B W Brown, M Rozencweig, et al.
Pageof 5